Orphazyme
Orphazyme: Further NPC data provides further answers (Redeye)
2020-01-03 15:44
Orphazyme has reported long-awaited results from the open-label phase 2/3 extension study (OLE). We here give our initial reflections and indicative updates to our valuation. We will start to work on a subsequent update immediately.
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se